| Code | CSB-MP023955MO2 |
| Abbreviation | Recombinant Mouse Tnf protein, partial (Active) |
| MSDS | |
| Size | $118 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
TNF-α drives apoptosis, inflammation, and immune cell activation through TNFR1 and TNFR2, making precise control of its bioactivity essential for mechanistic studies of cytokine signaling and tumor immunology. This mammalian-expressed fragment spanning residues 80–235 demonstrates potent cytotoxic activity in L-929 fibroblast assays with an ED50 of 26.52–46.24 pg/mL and binds human TNFRSF1A with an EC50 of 5.832–6.608 ng/mL and a KD of 1.24 nM, confirming receptor engagement at physiologically relevant concentrations suitable for NF-κB and MAPK pathway activation studies. The endotoxin level below 1.0 EU/μg prevents LPS-driven artifacts in primary immune cell assays, supporting use in macrophage polarization experiments, T-cell co-stimulation protocols, and in vivo inflammation models where TNF-α–specific effects must be isolated from innate immune contamination. Purity exceeding 95% by SDS-PAGE, combined with quantitative receptor-binding validation, provides a reliable basis for antibody development, ELISA standardization, and dose-response studies in cancer immunotherapy research.
There are currently no reviews for this product.